Jiaxue Wang
Beijing, 100101, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Dissecting the Genetic Basis of Low Back Pain Independent of BMI Through Genomic Structural Equation Modeling.
Journal: Journal of pain research
Published: November 15, 2025
Incidence, Causes, and Timing of Unplanned Reoperations Following Three-Column Osteotomy for Pediatric and Adult Spinal Deformities: A Long-Term Single Center Study.
Journal: Orthopaedic surgery
Published: July 29, 2025
Vacancy engineering enhanced photothermal-catalytic properties of Co9S8-x nanozymes for mild NIR-II hyperthermia-amplified nanocatalytic cancer therapy.
Journal: Journal of materials chemistry. B
Published: January 20, 2025
Osteoarthritis Incidence Trends Globally, Regionally, and Nationally, 1990-2019: An Age-Period-Cohort Analysis.
Journal: Musculoskeletal care
Published: November 27, 2024
Pharmacokinetic bioequivalence, safety, and immunogenicity of GB222, a bevacizumab biosimilar candidate, and bevacizumab in Chinese healthy males: a randomized clinical trial.
Journal: Expert opinion on biological therapy
Published: July 08, 2021
Randomised, double-blind, multicentre, phase Ⅰ/Ⅱ dose escalation and expansion trial of GR1501 in patients with plaque psoriasis: study protocol.
Journal: BMJ open
Published: November 25, 2020
rHuPH20-facilitated subcutaneous administration of monoclonal antibodies in cancer therapy.
Journal: Immunotherapy
Published: November 17, 2020
Comparative efficacy and safety of 8 GLP-1RAs in patients with type 2 diabetes: A network meta-analysis.
Journal: Diabetes research and clinical practice
Published: August 15, 2020
Corrigendum to 'A randomized controlled, dose-escalation study of SSS07, a humanized rabbit anti-human TNF alpha antibody, in healthy Chinese adults'. [Int. Immunopharmacol. 75 (2019) 105807].
Journal: International immunopharmacology
Published: August 15, 2020
A randomized phase I clinical trial comparing the pharmacokinetic, safety, and immunogenicity of potential biosimilar recombinant human HER2 monoclonal antibody for injection and trastuzumab in healthy Chinese adults.
Journal: Expert opinion on investigational drugs
Published: June 30, 2020
A Randomized Study on the Bioequivalence of Desloratadine in Healthy Chinese Subjects and the Association of Different Metabolic Phenotypes With UGT2B10 and CYP2C8 Genotypes.
Journal: Current drug metabolism
Published: June 09, 2020
A Systematic Review and Meta-Analysis: Safety and Efficacy of Mesenchymal Stem Cells Therapy for Heart Failure.
Journal: Current stem cell research & therapy
Published: April 15, 2020
Last Updated: 09/26/2026